Myofibroblasts

Experimental Eye Research

Volumn 142, Issue , 2015, Pages 56-70

  Hinz, Boris ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Contraction; Contracture; Fibrosis; Inflammation; Scar; Stress fiber; Transforming growth factor beta; smooth muscle actin

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; F ACTIN; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GAMMA INTERFERON; HYALURONIC ACID; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA3; VANILLOID RECEPTOR; VINCULIN; WNT PROTEIN; ACTIN; SIGNAL PEPTIDE;

CANCER GROWTH; CELL ACTIVATION; CELL STRESS; DIAGNOSTIC VALUE; EXTRACELLULAR MATRIX; HUMAN; INFLAMMATION; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; REVIEW; WOUND HEALING; CELL DIFFERENTIATION; CYTOLOGY; EYE INJURY; FIBROBLAST; FIBROSIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACTINS; CELL DIFFERENTIATION; COLLAGEN; EYE INJURIES; FIBROBLASTS; FIBROSIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOFIBROBLASTS; WOUND HEALING;

EID: 84937828512     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2015.07.009     Document Type: Review

References (379)

1. Abercrombie M., Flint M.H., James D.W. Wound contraction in relation to collagen formation in scorbutic guinea pigs. J. Embryol. Exp. Morphol. 1956, 4:167-175.
2. Abu El-Asrar A.M., De Hertogh G., van den Eynde K., Alam K., Van Raemdonck K., Opdenakker G., Van Damme J., Geboes K., Struyf S. Myofibroblasts in proliferative diabetic retinopathy can originate from infiltrating fibrocytes and through endothelial-to-mesenchymal transition (EndoMT). Exp. Eye Res. 2015, 132:179-189.
3. Acharya A., Baek S.T., Huang G., Eskiocak B., Goetsch S., Sung C.Y., Banfi S., Sauer M.F., Olsen G.S., Duffield J.S., Olson E.N., Tallquist M.D. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 2012, 139:2139-2149.
4. Acharya P.S., Majumdar S., Jacob M., Hayden J., Mrass P., Weninger W., Assoian R.K., Pure E. Fibroblast migration is mediated by CD44-dependent TGF beta activation. J. Cell Sci. 2008, 121:1393-1402.
5. Achterberg V.F., Buscemi L., Diekmann H., Smith-Clerc J., Schwengler H., Meister J.J., Wenck H., Gallinat S., Hinz B. The nano-scale mechanical properties of the extracellular matrix regulate dermal fibroblast function. J. Invest Dermatol. 2014, 134:1862-1872.
6. Adapala R.K., Thoppil R.J., Luther D.J., Paruchuri S., Meszaros J.G., Chilian W.M., Thodeti C.K. TRPV4 channels mediate cardiac fibroblast differentiation by integrating mechanical and soluble signals. J. Mol. Cell Cardiol. 2013, 54:45-52.
7. Akasaka Y., Ono I., Tominaga A., Ishikawa Y., Ito K., Suzuki T., Imaizumi R., Ishiguro S., Jimbow K., Ishii T. Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of alpha-smooth muscle actin, leading to reduction of wound contraction. Wound Repair Regen. 2007, 15:378-389.
8. Amini-Nik S., Cambridge E., Yu W., Guo A., Whetstone H., Nadesan P., Poon R., Hinz B., Alman B.A. Beta-catenin-regulated myeloid cell adhesion and migration determine wound healing. J. Clin. Investig. 2014, 124:2599-2610.
9. Anderson S., DiCesare L., Tan I., Leung T., SundarRaj N. Rho-mediated assembly of stress fibers is differentially regulated in corneal fibroblasts and myofibroblasts. Exp. Cell Res. 2004, 298:574-583.
10. Annes J.P., Chen Y., Munger J.S., Rifkin D.B. Integrin αVβ6-mediated activation of latent TGF-β requires the latent TGF-β binding protein-1. J. Cell Biol. 2004, 165:723-734.
11. Arnoldi R., Chaponnier C., Gabbiani G., Hinz B. Heterogeneity of smooth muscle. Muscle: Fundamental Biology and Mechanisms of Disease 2012, 1183-1195. Elsevier Inc. J. Hill (Ed.).
12. Asano Y. Future treatments in systemic sclerosis. J. Dermatol. 2010, 37:54-70.
13. Aumiller V., Balsara N., Wilhelm J., Gunther A., Konigshoff M. Wnt/beta-catenin signaling induces IL-1beta expression by alveolar epithelial cells in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2013, 49:96-104.
14. Baarsma H.A., Spanjer A.I., Haitsma G., Engelbertink L.H., Meurs H., Jonker M.R., Timens W., Postma D.S., Kerstjens H.A., Gosens R. Activation of Wnt/beta-catenin signaling in pulmonary fibroblasts by TGF-beta(1) is increased in chronic obstructive pulmonary disease. PLoS One 2011, 6:e25450.
15. Baker A.M., Bird D., Lang G., Cox T.R., Erler J.T. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK. Oncogene 2013, 32:1863-1868.
16. Baldwin A.K., Simpson A., Steer R., Cain S.A., Kielty C.M. Elastic fibres in health and disease. Expert Rev. Mol. Med. 2013, 15:e8.
17. Balestrini J., Hinz B. The mechanical regulation of myofibroblasts; mechanically-guided matrix remodeling and prevention of fibrosis in regenerative medicine. Cells, Forces and the Microenvironment 2014, Pan Staford Publishing Pte Ltd, Singapore. A.E.P.A.C.M. Cuerrier (Ed.).
18. Barbosa F.L., Chaurasia S.S., Cutler A., Asosingh K., Kaur H., de Medeiros F.W., Agrawal V., Wilson S.E. Corneal myofibroblast generation from bone marrow-derived cells. Exp. Eye Res. 2010, 91:92-96.
19. Barbosa F.L., Chaurasia S.S., Kaur H., de Medeiros F.W., Agrawal V., Wilson S.E. Stromal interleukin-1 expression in the cornea after haze-associated injury. Exp. Eye Res. 2010, 91:456-461.
20. Barbosa F.L., Lin M., Santhiago M.R., Singh V., Agrawal V., Wilson S.E. Interleukin-1 receptor role in the viability of corneal myofibroblasts. Exp. Eye Res. 2012, 96:65-69.
21. Bargagna-Mohan P., Paranthan R.R., Hamza A., Zhan C.G., Lee D.M., Kim K.B., Lau D.L., Srinivasan C., Nakayama K., Nakayama K.I., Herrmann H., Mohan R. Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin. J. Biol. Chem. 2012, 287:989-1006.
22. Barry-Hamilton V., Spangler R., Marshall D., McCauley S., Rodriguez H.M., Oyasu M., Mikels A., Vaysberg M., Ghermazien H., Wai C., Garcia C.A., Velayo A.C., Jorgensen B., Biermann D., Tsai D., Green J., Zaffryar-Eilot S., Holzer A., Ogg S., Thai D., Neufeld G., Van Vlasselaer P., Smith V. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat. Med. 2010, 16:1009-1017.
23. Benzonana G., Skalli O., Gabbiani G. Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues. Cell Motil. Cytoskelet. 1988, 11:260-274.
24. Berthaut A., Mirshahi P., Benabbou N., Ducros E., Agra A., Therwath A., Legeais J.M., Mirshahi M. Insulin growth factor promotes human corneal fibroblast network formation in vitro. Invest Ophthalmol. Vis. Sci. 2011, 52:7647-7653.
25. Bettahi I., Sun H., Gao N., Wang F., Mi X., Chen W., Liu Z., Yu F.S. Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: hyperglycemia-suppressed TGFbeta3 expression contributes to the delay of epithelial wound healing in diabetic corneas. Diabetes 2014, 63:715-727.
26. Beyer C., Reichert H., Akan H., Mallano T., Schramm A., Dees C., Palumbo-Zerr K., Lin N.Y., Distler A., Gelse K., Varga J., Distler O., Schett G., Distler J.H. Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis. Ann. Rheum. Dis. 2013, 72:1255-1258.
27. Biernacka A., Dobaczewski M., Frangogiannis N.G. TGF-beta signaling in fibrosis. Growth Factors 2011, 29:196-202.
28. Blalock T.D., Duncan M.R., Varela J.C., Goldstein M.H., Tuli S.S., Grotendorst G.R., Schultz G.S. Connective tissue growth factor expression and action in human corneal fibroblast cultures and rat corneas after photorefractive keratectomy. Investig. Ophthalmol. Vis. Sci. 2003, 44:1879-1887.
29. Blanco-Mezquita J.T., Hutcheon A.E., Stepp M.A., Zieske J.D. alphaVbeta6 integrin promotes corneal wound healing. Investig. Ophthalmol. Vis. Sci. 2011, 52:8505-8513.
30. Bochaton-Piallat M.L., Kapetanios A.D., Donati G., Redard M., Gabbiani G., Pournaras C.J. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Investig. Ophthalmol. Vis. Sci. 2000, 41:2336-2342.
31. Bond J.E., Kokosis G., Ren L., Selim M.A., Bergeron A., Levinson H. Wound contraction is attenuated by fasudil inhibition of Rho-associated kinase. Plast. Reconstr. Surg. 2011, 128:438e-450e.
32. Bonner J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev. 2004, 15:255-273.
33. Boote C., Du Y., Morgan S., Harris J., Kamma-Lorger C.S., Hayes S., Lathrop K.L., Roh D.S., Burrow M.K., Hiller J., Terrill N.J., Funderburgh J.L., Meek K.M. Quantitative assessment of ultrastructure and light scatter in mouse corneal debridement wounds. Investig. Ophthalmol. Vis. Sci. 2012, 53:2786-2795.
34. Borthwick L.A., Wynn T.A., Fisher A.J. Cytokine mediated tissue fibrosis. Biochim. Biophys. Acta 2013, 1832:1049-1060.
35. Braitsch C.M., Kanisicak O., van Berlo J.H., Molkentin J.D., Yutzey K.E. Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease. J. Mol. Cell. Cardiol. 2013, 65:108-119.
36. Brancato S.K., Albina J.E. Wound macrophages as key regulators of repair: origin, phenotype, and function. Am. J. Pathol. 2011, 178:19-25.
37. Brigstock D.R. Connective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals. J. Cell Commun. Signal 2010, 4:1-4.
38. Brisset A.C., Hao H., Camenzind E., Bacchetta M., Geinoz A., Sanchez J.C., Chaponnier C., Gabbiani G., Bochaton-Piallat M.L. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ. Res. 2007, 100:1055-1062.
39. Buscemi L., Ramonet D., Klingberg F., Formey A., Smith-Clerc J., Meister J.J., Hinz B. The single-molecule mechanics of the latent TGF-beta1 complex. Curr. Biol. 2011, 21:2046-2054.
40. Butcher D.T., Alliston T., Weaver V.M. A tense situation: forcing tumour progression. Nat. Rev. Cancer 2009, 9:108-122.
41. Bystrom B., Carracedo S., Behndig A., Gullberg D., Pedrosa-Domellof F. Alpha11 integrin in the human cornea: importance in development and disease. Investig. Ophthalmol. Vis. Sci. 2009, 50:5044-5053.
42. Calvo F., Ege N., Grande-Garcia A., Hooper S., Jenkins R.P., Chaudhry S.I., Harrington K., Williamson P., Moeendarbary E., Charras G., Sahai E. Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nat. Cell Biol. 2013, 15:637-646.
43. Campanholle G., Ligestri G., Gharib S.A., Duffield J.S. Cellular mechanisms of tissue Fibrosis. 3. Novel mechanisms of kidney fibrosis. Am. J. Physiol. Cell Physiol. 2013, 304:C591-C603.
44. Carracedo S., Lu N., Popova S.N., Jonsson R., Eckes B., Gullberg D. The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation. J. Biol. Chem. 2010, 285:10434-10445.
45. Carrington L.M., Albon J., Anderson I., Kamma C., Boulton M. Differential regulation of key stages in early corneal wound healing by TGF-beta isoforms and their inhibitors. Investig. Ophthalmol. Vis. Sci. 2006, 47:1886-1894.
46. Carter R.T. The role of integrins in corneal wound healing. Vet. Ophthalmol. 2009, 12(Suppl. 1):2-9.
47. Cash J.L., Bass M.D., Campbell J., Barnes M., Kubes P., Martin P. Resolution mediator chemerin15 reprograms the wound microenvironment to promote repair and reduce scarring. Curr. Biol. 2014, 24:1406-1414.
48. Castelino F.V., Varga J. Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapy. Curr. Opin. Rheumatol. 2014, 26:607-614.
49. Chanoki M., Ishii M., Kobayashi H., Fushida H., Yashiro N., Hamada T., Ooshima A. Increased expression of lysyl oxidase in skin with scleroderma. Br. J. Dermatol. 1995, 133:710-715.
50. Chaponnier C., Goethals M., Janmey P.A., Gabbiani F., Gabbiani G., Vandekerckhove J. The specific NH2-terminal sequence Ac-EEED of alpha-smooth muscle actin plays a role in polymerization in vitro and in vivo. J. Cell Biol. 1995, 130:887-895.
51. Chaurasia S.S., Kaur H., de Medeiros F.W., Smith S.D., Wilson S.E. Dynamics of the expression of intermediate filaments vimentin and desmin during myofibroblast differentiation after corneal injury. Exp. Eye Res. 2009, 89:133-139.
52. Chen J., Guerriero E., Sado Y., SundarRaj N. Rho-mediated regulation of TGF-beta1- and FGF-2-induced activation of corneal stromal keratocytes. Investig. Ophthalmol. Vis. Sci. 2009, 50:3662-3670.
53. Chen J., Li H., SundarRaj N., Wang J.H. Alpha-smooth muscle actin expression enhances cell traction force. Cell Motil. Cytoskelet. 2007, 64:248-257.
54. Chen J., Wong-Chong J., SundarRaj N. FGF-2- and TGF-beta1-induced downregulation of lumican and keratocan in activated corneal keratocytes by JNK signaling pathway. Investig. Ophthalmol. Vis. Sci. 2011, 52:8957-8964.
55. Chen J.H., Chen W.L., Sider K.L., Yip C.Y., Simmons C.A. beta-catenin mediates mechanically regulated, transforming growth factor-beta1-induced myofibroblast differentiation of aortic valve interstitial cells. Arterioscler. Thromb. Vasc. Biol. 2011, 31:590-597.
56. Chen X., Xiao W., Wang W., Luo L., Ye S., Liu Y. The complex interplay between ERK1/2, TGFbeta/Smad, and Jagged/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells. PLoS One 2014, 9:e96365.
57. Chen Y.T., Chang F.C., Wu C.F., Chou Y.H., Hsu H.L., Chiang W.C., Shen J., Chen Y.M., Wu K.D., Tsai T.J., Duffield J.S., Lin S.L. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int. 2011, 80:1170-1181.
58. Chong C.C., Stump R.J., Lovicu F.J., McAvoy J.W. TGFbeta promotes Wnt expression during cataract development. Exp. Eye Res. 2009, 88:307-313.
59. Chong J.J., Reinecke H., Iwata M., Torok-Storb B., Stempien-Otero A., Murry C.E. Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev. 2013, 22:1932-1943.
60. Christ A.F., Franze K., Gautier H., Moshayedi P., Fawcett J., Franklin R.J., Karadottir R.T., Guck J. Mechanical difference between white and gray matter in the rat cerebellum measured by scanning force microscopy. J. Biomech. 2010, 43:2986-2992.
61. Cleary P.E., Minckler D.S., Ryan S.J. Ultrastructure of traction retinal detachment in rhesus monkey eyes after a posterior penetrating ocular injury. Am. J. Ophthalmol. 1980, 90:829-845.
62. Cleary P.E., Ryan S.J. Mechanisms in traction retinal detachment. Dev. Ophthalmol. 1981, 2:328-333.
63. Clement S., Hinz B., Dugina V., Gabbiani G., Chaponnier C. The N-terminal Ac-EEED sequence plays a role in α-smooth-muscle actin incorporation into stress fibers. J. Cell Sci. 2005, 118:1395-1404.
64. Colwell A.S., Longaker M.T., Lorenz H.P. Fetal wound healing. Front. Biosci. 2003, 8:s1240-1248.
65. Cordeiro M.F., Gay J.A., Khaw P.T. Human anti-transforming growth factor-beta2 antibody: a new glaucoma anti-scarring agent. Investig. Ophthalmol. Vis. Sci. 1999, 40:2225-2234.
66. Cordeiro M.F., Reichel M.B., Gay J.A., D'Esposita F., Alexander R.A., Khaw P.T. Transforming growth factor-beta1, -beta2, and -beta3 in vivo: effects on normal and mitomycin C-modulated conjunctival scarring. Investig. Ophthalmol. Vis. Sci. 1999, 40:1975-1982.
67. Counts D.F., Evans J.N., Dipetrillo T.A., Sterling K.M., Kelley J. Collagen lysyl oxidase activity in the lung increases during bleomycin-induced lung fibrosis. J. Pharmacol. Exp. Ther. 1981, 219:675-678.
68. Cox T.R., Erler J.T. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Model Mech. 2011, 4:165-178.
69. Crider B.J., Risinger G.M., Haaksma C.J., Howard E.W., Tomasek J.J. Myocardin-related transcription factors A and B are key regulators of TGF-beta1-induced fibroblast to myofibroblast differentiation. J. Investig. Dermatol. 2011, 131:2378-2385.
70. Cushing M.C., Mariner P.D., Liao J.T., Sims E.A., Anseth K.S. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. Faseb J. 2008, 22:1769-1777.
71. Davidson J.M., Broadley K.N., Quaglino D. Reversal of the wound healing deficit in diabetic rats by combined basic fibroblast growth factor and transforming growth factor-beta1 therapy. Wound Repair Regen. 1997, 5:77-88.
72. Davies L.C., Jenkins S.J., Allen J.E., Taylor P.R. Tissue-resident macrophages. Nat. Immunol. 2013, 14:986-995.
73. Davis J., Molkentin J.D. Myofibroblasts: trust your heart and let fate decide. J. Mol. Cell Cardiol. 2014, 70:9-18.
74. Dawes L.J., Sleeman M.A., Anderson I.K., Reddan J.R., Wormstone I.M. TGFbeta/Smad4-dependent and -independent regulation of human lens epithelial cells. Investig. Ophthalmol. Vis. Sci. 2009, 50:5318-5327.
75. Dees C., Distler J.H. Canonical Wnt signalling as a key regulator of fibrogenesis - implications for targeted therapies?. Exp. Dermatol. 2013, 22:710-713.
76. Dendooven A., Gerritsen K.G., Nguyen T.Q., Kok R.J., Goldschmeding R. Connective tissue growth factor (CTGF/CCN2) ELISA: a novel tool for monitoring fibrosis. Biomarkers 2011, 16:289-301.
77. Desmoulière A., Geinoz A., Gabbiani F., Gabbiani G. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 1993, 122:103-111.
78. Desmoulière A., Redard M., Darby I., Gabbiani G. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 1995, 146:56-66.
79. Di Donato A., Ghiggeri G.M., Di Duca M., Jivotenko E., Acinni R., Campolo J., Ginevri F., Gusmano R. Lysyl oxidase expression and collagen cross-linking during chronic adriamycin nephropathy. Nephron 1997, 76:192-200.
80. Dooley S., Said H.M., Gressner A.M., Floege J., En-Nia A., Mertens P.R. Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J. Biol. Chem. 2006, 281:1784-1795.
81. Doyle J.J., Gerber E.E., Dietz H.C. Matrix-dependent perturbation of TGFbeta signaling and disease. FEBS Lett. 2012, 586:2003-2015.
82. Dreier B., Thomasy S.M., Mendonsa R., Raghunathan V.K., Russell P., Murphy C.J. Substratum compliance modulates corneal fibroblast to myofibroblast transformation. Investig. Ophthalmol. Vis. Sci. 2013, 54:5901-5907.
83. Driskell R.R., Lichtenberger B.M., Hoste E., Kretzschmar K., Simons B.D., Charalambous M., Ferron S.R., Herault Y., Pavlovic G., Ferguson-Smith A.C., Watt F.M. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature 2013, 504:277-281.
84. Duffield J.S. Cellular and molecular mechanisms in kidney fibrosis. J. Clin. Investig. 2014, 124:2299-2306.
85. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J.P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Investig. 2005, 115:56-65.
86. Duffield J.S., Lupher M., Thannickal V.J., Wynn T.A. Host responses in tissue repair and fibrosis. Annu. Rev. Pathol. 2013, 8:241-276.
87. Dugina V., Fontao L., Chaponnier C., Vasiliev J., Gabbiani G. Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J. Cell Sci. 2001, 114:3285-3296.
88. Dulauroy S., Di Carlo S.E., Langa F., Eberl G., Peduto L. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat. Med. 2012, 18:1262-1270.
89. Dupps W.J., Wilson S.E. Biomechanics and wound healing in the cornea. Exp. Eye Res. 2006, 83:709-720.
90. Duscher D., Maan Z.N., Wong V.W., Rennert R.C., Januszyk M., Rodrigues M., Hu M., Whitmore A.J., Whittam A.J., Longaker M.T., Gurtner G.C. Mechanotransduction and fibrosis. J. Biomech. 2014, 47:1997-2005.
91. Elkin B.S., Ilankovan A., Morrison B. Age-dependent regional mechanical properties of the rat hippocampus and cortex. J. Biomech. Eng. 2010, 132:011010.
92. Eming S.A., Krieg T., Davidson J.M. Inflammation in wound repair: molecular and cellular mechanisms. J. Investig. Dermatol. 2007, 127:514-525.
93. Engler A.J., Griffin M.A., Sen S., Bonnemann C.G., Sweeney H.L., Discher D.E. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J. Cell Biol. 2004, 166:877-887.
94. Etheredge L., Kane B.P., Valkov N., Adams S., Birk D.E., Hassell J.R. Enhanced cell accumulation and collagen processing by keratocytes cultured under agarose and in media containing IGF-I, TGF-beta or PDGF. Matrix Biol. 2010, 29:519-524.
95. Ferrari G., Bignami F., Giacomini C., Franchini S., Rama P. Safety and efficacy of topical infliximab in a mouse model of ocular surface scarring. Investig. Ophthalmol. Vis. Sci. 2013, 54:1680-1688.
96. Flanders K.C., Thompson N.L., Cissel D.S., Van Obberghen-Schilling E., Baker C.C., Kass M.E., Ellingsworth L.R., Roberts A.B., Sporn M.B. Transforming growth factor-beta 1: histochemical localization with antibodies to different epitopes. J. Cell Biol. 1989, 108:653-660.
97. Folger P.A., Zekaria D., Grotendorst G., Masur S.K. Transforming growth factor-beta-stimulated connective tissue growth factor expression during corneal myofibroblast differentiation. Investig. Ophthalmol. Vis. Sci. 2001, 42:2534-2541.
98. Follonier Castella L., Buscemi L., Godbout C., Meister J.J., Hinz B. A new lock-step mechanism of matrix remodelling based on subcellular contractile events. J. Cell Sci. 2010, 123:1751-1760.
99. Forbes S.J., Rosenthal N. Preparing the ground for tissue regeneration: from mechanism to therapy. Nat. Med. 2014, 20:857-869.
100. Friedman S.L., Sheppard D., Duffield J.S., Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci. Transl. Med. 2013, 5:167sr161.
101. Gabbiani G., Ryan G.B., Majno G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971, 27:549-550.
102. Gamulescu M.A., Chen Y., He S., Spee C., Jin M., Ryan S.J., Hinton D.R. Transforming growth factor beta2-induced myofibroblastic differentiation of human retinal pigment epithelial cells: regulation by extracellular matrix proteins and hepatocyte growth factor. Exp. Eye Res. 2006, 83:212-222.
103. Garana R.M., Petroll W.M., Chen W.T., Herman I.M., Barry P., Andrews P., Cavanagh H.D., Jester J.V. Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction. Investig. Ophthalmol. Vis. Sci. 1992, 33:3271-3282.
104. Garrett Q., Khaw P.T., Blalock T.D., Schultz G.S., Grotendorst G.R., Daniels J.T. Involvement of CTGF in TGF-beta1-stimulation of myofibroblast differentiation and collagen matrix contraction in the presence of mechanical stress. Investig. Ophthalmol. Vis. Sci. 2004, 45:1109-1116.
105. Gauglitz G.G., Korting H.C., Pavicic T., Ruzicka T., Jeschke M.G. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol. Med. 2011, 17:113-125.
106. Georges P.C., Hui J.J., Gombos Z., McCormick M.E., Wang A.Y., Uemura M., Mick R., Janmey P.A., Furth E.E., Wells R.G. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293:G1147-G1154.
107. Giacomini M.M., Travis M.A., Kudo M., Sheppard D. Epithelial cells utilize cortical actin/myosin to activate latent TGF-beta through integrin alpha(v)beta(6)-dependent physical force. Exp. Cell Res. 2012, 318:716-722.
108. Gibson D.J., Pi L., Sriram S., Mao C., Petersen B.E., Scott E.W., Leask A., Schultz G.S. Conditional knockout of CTGF affects corneal wound healing. Investig. Ophthalmol. Vis. Sci. 2014, 55:2062-2070.
109. Goffin J.M., Pittet P., Csucs G., Lussi J.W., Meister J.J., Hinz B. Focal adhesion size controls tension-dependent recruitment of alpha-smooth muscle actin to stress fibers. J. Cell Biol. 2006, 172:259-268.
110. Gomes B.A., Smadja D., Espana E.M., Ahn Ekong S., Netto M.V., Santhiago M.R. Very late-onset corneal scar triggered by trauma after photorefractive keratectomy. J. Cataract. Refract. Surg. 2012, 38:1694-1697.
111. Goren I., Allmann N., Yogev N., Schurmann C., Linke A., Holdener M., Waisman A., Pfeilschifter J., Frank S. A transgenic mouse model of inducible macrophage depletion: effects of diphtheria toxin-driven lysozyme M-specific cell lineage ablation on wound inflammatory, angiogenic, and contractive processes. Am. J. Pathol. 2009, 175:132-147.
112. Gritsenko P.G., Ilina O., Friedl P. Interstitial guidance of cancer invasion. J. Pathol. 2012, 226:185-199.
113. Group C.A.T.T.S., Khaw P., Grehn F., Hollo G., Overton B., Wilson R., Vogel R., Smith Z. A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology 2007, 114:1822-1830.
114. Guidry C., King J.L., Mason J.O. Fibrocontractive Muller cell phenotypes in proliferative diabetic retinopathy. Investig. Ophthalmol. Vis. Sci. 2009, 50:1929-1939.
115. Guo N., Li X., Mann M.M., Funderburgh M.L., Du Y., Funderburgh J.L. Hyaluronan synthesis mediates the fibrotic response of keratocytes to transforming growth factor beta. J. Biol. Chem. 2010, 285:32012-32019.
116. Gupta M., Korol A., West-Mays J.A. Nuclear translocation of myocardin-related transcription factor-A during transforming growth factor beta-induced epithelial to mesenchymal transition of lens epithelial cells. Mol. Vis. 2013, 19:1017-1028.
117. Halder G., Dupont S., Piccolo S. Transduction of mechanical and cytoskeletal cues by YAP and TAZ. Nat. Rev. Mol. Cell Biol. 2012, 13:591-600.
118. Hales A.M., Schulz M.W., Chamberlain C.G., McAvoy J.W. TGF-beta 1 induces lens cells to accumulate alpha-smooth muscle actin, a marker for subcapsular cataracts. Curr. Eye Res. 1994, 13:885-890.
119. Hamburg-Schields E., DiNuoscio G.J., Mullin N.K., Lafayatis R., Atit R.P. Sustained beta-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes. J. Pathol. 2014, 235:686-697.
120. Han H., Wecker T., Grehn F., Schlunck G. Elasticity-dependent modulation of TGF-beta responses in human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 2011, 52:2889-2896.
121. Hassell J.R., Birk D.E. The molecular basis of corneal transparency. Exp. Eye Res. 2010, 91:326-335.
122. He J., Bazan H.E. Synergistic effect of platelet-activating factor and tumor necrosis factor-alpha on corneal myofibroblast apoptosis. Investig. Ophthalmol. Vis. Sci. 2006, 47:883-891.
123. He L., Marneros A.G. Macrophages are essential for the early wound healing response and the formation of a fibrovascular scar. Am. J. Pathol. 2013, 182:2407-2417.
124. Hecker L., Jagirdar R., Jin T., Thannickal V.J. Reversible differentiation of myofibroblasts by MyoD. Exp. Cell Res. 2011, 317:1914-1921.
125. Heldin C.H. Targeting the PDGF signaling pathway in tumor treatment. Cell Commun. Signal 2013, 11:97.
126. Henderson N.C., Arnold T.D., Katamura Y., Giacomini M.M., Rodriguez J.D., McCarty J.H., Pellicoro A., Raschperger E., Betsholtz C., Ruminski P.G., Griggs D.W., Prinsen M.J., Maher J.J., Iredale J.P., Lacy-Hulbert A., Adams R.H., Sheppard D. Targeting of alpha integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat. Med. 2013, 19:1617-1624.
127. Henderson N.C., Sheppard D. Integrin-mediated regulation of TGF beta in fibrosis. Biochim. Biophys. Acta 2013, 1832:891-896.
128. Higashi K., Inagaki Y., Fujimori K., Nakao A., Kaneko H., Nakatsuka I. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem. 2003, 278:43470-43479.
129. Hinz B. Masters and servants of the force: the role of matrix adhesions in myofibroblast force perception and transmission. Eur. J. Cell Biol. 2006, 85:175-181.
130. Hinz B. Formation and function of the myofibroblast during tissue repair. J. Investig. Dermatol. 2007, 127:526-537.
131. Hinz B. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr. Rheumatol. Rep. 2009, 11:120-126.
132. Hinz B. The myofibroblast in connective tissue repair and regeneration. Regenerative Medicine and Biomaterials for the Repair of Connective Tissues 2010, 39-82. Woodhead Publishing Ltd., Cambridge, UK. C.A.J. Ralphs (Ed.).
133. Hinz B. The myofibroblast: paradigm for a mechanically active cell. J. Biomech. 2010, 43:146-155.
134. Hinz B. It has to be the alpha: myofibroblast integrins activate latent TGF-beta1. Nat. Med. 2013, 19:1567-1568.
135. Hinz B. Matrix mechanics and regulation of the fibroblast phenotype. Periodontol 2013, 2000(63):14-28.
136. Hinz B. The matrix and the transforming growth factor: tale of a strained relationship. Matrix Biol. 2015, [e-pub ahead of print].
137. Hinz B., Celetta G., Tomasek J.J., Gabbiani G., Chaponnier C. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol. Biol. Cell 2001, 12:2730-2741.
138. Hinz B., Dugina V., Ballestrem C., Wehrle-Haller B., Chaponnier C. Alpha-smooth muscle actin is crucial for focal adhesion maturation in myofibroblasts. Mol. Biol. Cell 2003, 14:2508-2519.
139. Hinz B., Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: role in connective tissue remodeling. Thromb. Haemost. 2003, 90:993-1002.
140. Hinz B., Gabbiani G. The role of myofibroblasts in Dupuytren's disease: fundamental aspects of contraction and therapeutic perspectives. Morbus Dupuytren and Related Hyperproliferative Disorders: Principles, Research, and Clinical Perspectives 2011, Springer Verlag. C. Eaton, M.H.S. (Eds.).
141. Hinz B., Gabbiani G., Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force generation by the myofibroblast in vitro and in vivo. J. Cell Biol. 2002, 157:657-663.
142. Hinz B., Gabbiani G., Seemayer T.A., Schürch W. Myofibroblast. Histology for Pathologists 2012, 131-177. Lippincott-Williams & Wilkins Pub., Philadelphia, U.S.A. fouth ed. S.E. Mills (Ed.).
143. Hinz B., McCulloch C.M. Integrin function in heart fibrosis: mechanical strain, TGF-β1 activation and collagen glycation. Extracellular Matrix: Pathobiology and Signalling 2012, 407-431. DeGruyter, Berlin, Germany. N. Karamanos (Ed.).
144. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol. 2007, 170:1807-1816.
145. Hinz B., Phan S.H., Thannickal V.J., Prunotto M., Desmouliere A., Varga J., De Wever O., Mareel M., Gabbiani G. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 2012, 180:1340-1355.
146. Ho S.P., Marshall S.J., Ryder M.I., Marshall G.W. The tooth attachment mechanism defined by structure, chemical composition and mechanical properties of collagen fibers in the periodontium. Biomaterials 2007, 28:5238-5245.
147. Holbach L.M., Font R.L., Shivitz I.A., Jones D.B. Bilateral keloid-like myofibroblastic proliferations of the cornea in children. Ophthalmology 1990, 97:1188-1193.
148. Hong J.W., Liu J.J., Lee J.S., Mohan R.R., Mohan R.R., Woods D.J., He Y.G., Wilson S.E. Proinflammatory chemokine induction in keratocytes and inflammatory cell infiltration into the cornea. Investig. Ophthalmol. Vis. Sci. 2001, 42:2795-2803.
149. Horan G.S., Wood S., Ona V., Li D.J., Lukashev M.E., Weinreb P.H., Simon K.J., Hahm K., Allaire N.E., Rinaldi N.J., Goyal J., Feghali-Bostwick C.A., Matteson E.L., O'Hara C., Lafyatis R., Davis G.S., Huang X., Sheppard D., Violette S.M. Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammation. Am. J. Respir. Crit. Care Med. 2008, 177:56-65.
150. Hori K., Matsuda A., Ebihara N., Imai K., Mori K., Funaki T., Watanabe Y., Nakatani S., Okada K., Matsuo O., Murakami A. Involvement of plasminogen activator inhibitor-1 in the pathogenesis of atopic cataracts. Investig. Ophthalmol. Vis. Sci. 2012, 53:1846-1851.
151. Huang T., Schor S.L., Hinck A.P. Biological activity differences between TGF-beta1 and TGF-beta3 correlate with differences in the rigidity and arrangement of their component monomers. Biochemistry 2014, 53:5737-5749.
152. Huang X., Gai Y., Yang N., Lu B., Samuel C.S., Thannickal V.J., Zhou Y. Relaxin regulates myofibroblast contractility and protects against lung fibrosis. Am. J. Pathol. 2011, 179:2751-2765.
153. Huh M.I., Chang Y., Jung J.C. Temporal and spatial distribution of TGF-beta isoforms and signaling intermediates in corneal regenerative wound repair. Histol. Histopathol. 2009, 24:1405-1416.
154. Huh M.I., Kim Y.H., Park J.H., Bae S.W., Kim M.H., Chang Y., Kim S.J., Lee S.R., Lee Y.S., Jin E.J., Sonn J.K., Kang S.S., Jung J.C. Distribution of TGF-beta isoforms and signaling intermediates in corneal fibrotic wound repair. J. Cell Biochem. 2009, 108:476-488.
155. Ieronimakis N., Hays A.L., Janebodin K., Mahoney W.M., Duffield J.S., Majesky M.W., Reyes M. Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGFbeta1 signaling in the mdx mouse model of Duchenne muscular dystrophy. J. Mol. Cell Cardiol. 2013, 63:122-134.
156. Ishida I., Saika S., Okada Y., Ohnishi Y. Growth factor deposition in anterior subcapsular cataract. J. Cataract. Refract. Surg. 2005, 31:1219-1225.
157. Ito T., Williams J.D., Fraser D., Phillips A.O. Hyaluronan attenuates transforming growth factor-beta1-mediated signaling in renal proximal tubular epithelial cells. Am. J. Pathol. 2004, 164:1979-1988.
158. Iwayama T., Olson L.E. Involvement of PDGF in fibrosis and scleroderma: recent insights from animal models and potential therapeutic opportunities. Curr. Rheumatol. Rep. 2013, 15:304.
159. Izumi K., Kurosaka D., Iwata T., Oguchi Y., Tanaka Y., Mashima Y., Tsubota K. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing. Investig. Ophthalmol. Vis. Sci. 2006, 47:591-598.
160. Janmey P.A., Georges P.C., Hvidt S. Basic rheology for biologists. Methods Cell Biol. 2007, 83:3-27.
161. Jenkins G. The role of proteases in transforming growth factor-beta activation. Int. J. Biochem. Cell Biol. 2008, 40:1068-1078.
162. Jeon K.I., Kulkarni A., Woeller C.F., Phipps R.P., Sime P.J., Hindman H.B., Huxlin K.R. Inhibitory effects of PPARgamma ligands on TGF-beta1-induced corneal myofibroblast transformation. Am. J. Pathol. 2014, 184:1429-1445.
163. Jester J.V., Barry-Lane P.A., Cavanagh H.D., Petroll W.M. Induction of alpha-smooth muscle actin expression and myofibroblast transformation in cultured corneal keratocytes. Cornea 1996, 15:505-516.
164. Jester J.V., Brown D., Pappa A., Vasiliou V. Myofibroblast differentiation modulates keratocyte crystallin protein expression, concentration, and cellular light scattering. Investig. Ophthalmol. Vis. Sci. 2012, 53:770-778.
165. Jester J.V., Huang J., Petroll W.M., Cavanagh H.D. TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling. Exp. Eye Res. 2002, 75:645-657.
166. Jester J.V., Petroll W.M., Cavanagh H.D. Corneal stromal wound healing in refractive surgery: the role of myofibroblasts. Prog. Retin Eye Res. 1999, 18:311-356.
167. Johnson L.A., Rodansky E.S., Haak A.J., Larsen S.D., Neubig R.R., Higgins P.D. Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-beta-induced fibrogenesis in human colonic myofibroblasts. Inflamm. Bowel Dis. 2014, 20:154-165.
168. Jun J.I., Lau L.F. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat. Rev. Drug Discov. 2011, 10:945-963.
169. Kagan H.M. Lysyl oxidase: mechanism, regulation and relationship to liver fibrosis. Pathol. Res. Pract. 1994, 190:910-919.
170. Kahn M. Can we safely target the Wnt pathway?. Nat. Rev. Drug Discov. 2014, 13:513-532.
171. Kanangat S., Postlethwaite A.E., Higgins G.C., Hasty K.A. Novel functions of intracellular IL-1ra in human dermal Fibroblasts: Implications in the pathogenesis of fibrosis. J. Investig. Dermatol. 2006, 126:756-765.
172. Karamichos D., Hutcheon A.E., Zieske J.D. Transforming growth factor-beta3 regulates assembly of a non-fibrotic matrix in a 3D corneal model. J. Tissue Eng. Regen. Med. 2011, 5:e228-238.
173. Karamichos D., Hutcheon A.E., Zieske J.D. Reversal of fibrosis by TGF-beta3 in a 3D in vitro model. Exp. Eye Res. 2014, 124:31-36.
174. Karamichos D., Lakshman N., Petroll W.M. Regulation of corneal fibroblast morphology and collagen reorganization by extracellular matrix mechanical properties. Investig. Ophthalmol. Vis. Sci. 2007, 48:5030-5037.
175. Kaur H., Chaurasia S.S., Agrawal V., Suto C., Wilson S.E. Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1. Exp. Eye Res. 2009, 89:152-158.
176. Kaur H., Chaurasia S.S., de Medeiros F.W., Agrawal V., Salomao M.Q., Singh N., Ambati B.K., Wilson S.E. Corneal stroma PDGF blockade and myofibroblast development. Exp. Eye Res. 2009, 88:960-965.
177. Kawakita T., Espana E.M., He H., Li W., Liu C.Y., Tseng S.C. Intrastromal invasion by limbal epithelial cells is mediated by epithelial-mesenchymal transition activated by air exposure. Am. J. Pathol. 2005, 167:381-393.
178. Kawakita T., Espana E.M., Higa K., Kato N., Li W., Tseng S.C. Activation of Smad-mediated TGF-beta signaling triggers epithelial-mesenchymal transitions in murine cloned corneal progenitor cells. J. Cell Physiol. 2013, 228:225-234.
179. Khouw I.M., van Wachem P.B., Plantinga J.A., Vujaskovic Z., Wissink M.J., de Leij L.F., van Luyn M.J. TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro. Biomaterials 1999, 20:1815-1822.
180. Kirwan R.P., Leonard M.O., Murphy M., Clark A.F., O'Brien C.J. Transforming growth factor-beta-regulated gene transcription and protein expression in human GFAP-negative lamina cribrosa cells. Glia 2005, 52:309-324.
181. Kisseleva T., Brenner D.A. Is it the end of the line for the EMT?. Hepatology 2011, 53:1433-1435.
182. Kisseleva T., Cong M., Paik Y., Scholten D., Jiang C., Benner C., Iwaisako K., Moore-Morris T., Scott B., Tsukamoto H., Evans S.M., Dillmann W., Glass C.K., Brenner D.A. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9448-9453.
183. Klingberg F., Chow M.L., Koehler A., Boo S., Buscemi L., Quinn T.M., Costell M., Alman B.A., Genot E., Hinz B. Prestress in the extracellular matrix sensitizes latent TGF-beta1 for activation. J. Cell Biol. 2014, 207:283-297.
184. Klingberg F., Hinz B., White E.S. The myofibroblast matrix: implications for tissue repair and fibrosis. J. Pathol. 2013, 229:298-309.
185. Koivisto L., Heino J., Hakkinen L., Larjava H. Integrins in wound healing. Adv. Wound Care (New Rochelle) 2014, 3:762-783.
186. Kong P., Christia P., Frangogiannis N.G. The pathogenesis of cardiac fibrosis. Cell Mol. Life Sci. 2013, 71:549-574.
187. Kong P., Christia P., Saxena A., Su Y., Frangogiannis N.G. Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H1363-H1372.
188. Konigshoff M., Kramer M., Balsara N., Wilhelm J., Amarie O.V., Jahn A., Rose F., Fink L., Seeger W., Schaefer L., Gunther A., Eickelberg O. Wnt1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis. J. Clin. Investig. 2009, 119:772-787.
189. Kramann R., Schneider R.K., DiRocco D.P., Machado F., Fleig S., Bondzie P.A., Henderson J.M., Ebert B.L., Humphreys B.D. Perivascular gli1(+) progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 2015, 16:51-66.
190. Krizaj D., Ryskamp D.A., Tian N., Tezel G., Mitchell C.H., Slepak V.Z., Shestopalov V.I. From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma. Curr. Eye Res. 2014, 39:105-119.
191. LaGier A.J., Gordon G.M., Katzman L.R., Vasiliou V., Fini M.E. Mechanisms for PDGF, a serum cytokine, stimulating loss of corneal keratocyte crystallins. Cornea 2013, 32:1269-1275.
192. Larson B.J., Longaker M.T., Lorenz H.P. Scarless fetal wound healing: a basic science review. Plast. Reconstr. Surg. 2010, 126:1172-1180.
193. Le Hir M., Hegyi I., Cueni-Loffing D., Loffing J., Kaissling B. Characterization of renal interstitial fibroblast-specific protein 1/S100A4-positive cells in healthy and inflamed rodent kidneys. Histochem Cell Biol. 2005, 123:335-346.
194. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ. Res. 2010, 106:1675-1680.
195. Leask A., Parapuram S.K., Shi-Wen X., Abraham D.J. Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?. J. Cell Commun. Signal 2009, 3:89-94.
196. LeBleu V.S., Kalluri R. Blockade of PDGF receptor signaling reduces myofibroblast number and attenuates renal fibrosis. Kidney Int. 2011, 80:1119-1121.
197. Leight J.L., Wozniak M.A., Chen S., Lynch M.L., Chen C.S. Matrix rigidity regulates a switch between TGF-beta1-induced apoptosis and epithelial-mesenchymal transition. Mol. Biol. Cell 2012, 23:781-791.
198. Li D.Q., Lee S.B., Tseng S.C. Differential expression and regulation of TGF-beta1, TGF-beta2, TGF-beta3, TGF-betaRI, TGF-betaRII and TGF-betaRIII in cultured human corneal, limbal, and conjunctival fibroblasts. Curr. Eye Res. 1999, 19:154-161.
199. Li S., Li B., Jiang H., Wang Y., Qu M., Duan H., Zhou Q., Shi W. Macrophage depletion impairs corneal wound healing after autologous transplantation in mice. PLoS One 2013, 8:e61799.
200. Li Y., Jiang D., Liang J., Meltzer E.B., Gray A., Miura R., Wogensen L., Yamaguchi Y., Noble P.W. Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44. J. Exp. Med. 2011, 208:1459-1471.
201. Liedtke C., Luedde T., Sauerbruch T., Scholten D., Streetz K., Tacke F., Tolba R., Trautwein C., Trebicka J., Weiskirchen R. Experimental liver fibrosis research: update on animal models, legal issues and translational aspects. Fibrogenes. Tissue Repair 2013, 6:19.
202. Liu F., Lagares D., Choi K.M., Stopfer L., Marinkovic A., Vrbanac V., Probst C.K., Hiemer S.E., Sisson T.H., Horowitz J.C., Rosas I.O., Fredenburgh L.E., Feghali-Bostwick C., Varelas X., Tager A.M., Tschumperlin D.J. Mechanosignaling through YAP and TAZ drive fibroblast activation and fibrosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2015, 308:L344-L357.
203. Liu F., Tschumperlin D.J. Micro-mechanical characterization of lung tissue using atomic force microscopy. J. Vis. Exp. 2011, 54.
204. Liu J., Hales A.M., Chamberlain C.G., McAvoy J.W. Induction of cataract-like changes in rat lens epithelial explants by transforming growth factor beta. Investig. Ophthalmol. Vis. Sci. 1994, 35:388-401.
205. Liu S., Shi-wen X., Abraham D.J., Leask A. CCN2 is required for bleomycin-induced skin fibrosis in mice. Arthritis Rheum. 2011, 63:239-246.
206. Lopez J.I., Kang I., You W.K., McDonald D.M., Weaver V.M. In situ force mapping of mammary gland transformation. Integr. Biol. (Camb) 2011, 3:910-921.
207. Lovicu F.J., Shin E.H., McAvoy J.W. Fibrosis in the lens. Sprouty regulation of TGFbeta-signaling prevents lens EMT leading to cataract. Exp. Eye Res. 2015, [e-pub ahead of print].
208. Lu P., Weaver V.M., Werb Z. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 2012, 196:395-406.
209. Lucas T., Waisman A., Ranjan R., Roes J., Krieg T., Muller W., Roers A., Eming S.A. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 2010, 184:3964-3977.
210. Luchsinger L.L., Patenaude C.A., Smith B.D., Layne M.D. Myocardin-related transcription factor-A complexes activate type I collagen expression in lung fibroblasts. J. Biol. Chem. 2011, 286:44116-44125.
211. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat. Biotechnol. 2005, 23:47-55.
212. Majd H., Wipff P.J., Buscemi L., Bueno M., Vonwil D., Quinn T.M., Hinz B. A novel method of dynamic culture surface expansion improves mesenchymal stem cell proliferation and phenotype. Stem Cells 2009, 27:200-209.
213. Majkut S.F., Discher D.E. Cardiomyocytes from late embryos and neonates do optimal work and striate best on substrates with tissue-level elasticity: metrics and mathematics. Biomech. Model Mechanobiol. 2012, 11:1219-1225.
214. Maltseva O., Folger P., Zekaria D., Petridou S., Masur S.K. Fibroblast growth factor reversal of the corneal myofibroblast phenotype. Invest Ophthalmol. Vis. Sci. 2001, 42:2490-2495.
215. Mamuya F.A., Wang Y., Roop V.H., Scheiblin D.A., Zajac J.C., Duncan M.K. The roles of alphaV integrins in lens EMT and posterior capsular opacification. J. Cell Mol. Med. 2014, 18:656-670.
216. Mantovani A., Biswas S.K., Galdiero M.R., Sica A., Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J. Pathol. 2013, 229:176-185.
217. Margadant C., Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep. 2010, 11:97-105.
218. Marinkovic A., Liu F., Tschumperlin D.J. Matrices of physiologic stiffness potently inactivate idiopathic pulmonary fibrosis fibroblasts. Am. J. Respir. Cell Mol. Biol. 2013, 48:422-430.
219. Marinkovic A., Mih J.D., Park J.A., Liu F., Tschumperlin D.J. Improved throughput traction microscopy reveals pivotal role for matrix stiffness in fibroblast contractility and TGF-beta responsiveness. Am. J. Physiol. Lung Cell Mol. Physiol. 2012, 303:L169-L180.
220. Martin P., Leibovich S.J. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol. 2005, 15:599-607.
221. Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000 Prime Rep. 2014, 6:13.
222. Masszi A., Speight P., Charbonney E., Lodyga M., Nakano H., Szaszi K., Kapus A. Fate-determining mechanisms in epithelial-myofibroblast transition: major inhibitory role for Smad3. J. Cell Biol. 2010, 188:383-399.
223. Masur S.K., Conors R.J., Cheung J.K., Antohi S. Matrix adhesion characteristics of corneal myofibroblasts. Investig. Ophthalmol. Vis. Sci. 1999, 40:904-910.
224. Masur S.K., Dewal H.S., Dinh T.T., Erenburg I., Petridou S. Myofibroblasts differentiate from fibroblasts when plated at low density. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:4219-4223.
225. Matsuba M., Hutcheon A.E., Zieske J.D. Localization of thrombospondin-1 and myofibroblasts during corneal wound repair. Exp. Eye Res. 2011, 93:534-540.
226. Mederacke I., Hsu C.C., Troeger J.S., Huebener P., Mu X., Dapito D.H., Pradere J.P., Schwabe R.F. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat. Commun. 2013, 4:2823.
227. Meyer-ter-Vehn T., Han H., Grehn F., Schlunck G. Extracellular matrix elasticity modulates TGF-beta-induced p38 activation and myofibroblast transdifferentiation in human tenon fibroblasts. Investig. Ophthalmol. Vis. Sci. 2011, 52:9149-9155.
228. Meyer-ter-Vehn T., Sieprath S., Katzenberger B., Gebhardt S., Grehn F., Schlunck G. Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human tenon fibroblasts. Investig. Ophthalmol. Vis. Sci. 2006, 47:4895-4904.
229. Minagawa S., Lou J., Seed R.I., Cormier A., Wu S., Cheng Y., Murray L., Tsui P., Connor J., Herbst R., Govaerts C., Barker T., Cambier S., Yanagisawa H., Goodsell A., Hashimoto M., Brand O.J., Cheng R., Ma R., McKnelly K.J., Wen W., Hill A., Jablons D., Wolters P., Kitamura H., Araya J., Barczak A.J., Erle D.J., Reichardt L.F., Marks J.D., Baron J.L., Nishimura S.L. Selective targeting of TGF-beta activation to treat fibroinflammatory airway disease. Sci. Transl. Med. 2014, 6. 241ra279.
230. Mirza R., DiPietro L.A., Koh T.J. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am. J. Pathol. 2009, 175:2454-2462.
231. Miyazaki K., Okada Y., Yamanaka O., Kitano A., Ikeda K., Kon S., Uede T., Rittling S.R., Denhardt D.T., Kao W.W., Saika S. Corneal wound healing in an osteopontin-deficient mouse. Investig. Ophthalmol. Vis. Sci. 2008, 49:1367-1375.
232. Modarressi A., Pietramaggiori G., Godbout C., Vigato E., Pittet B., Hinz B. Hypoxia impairs skin myofibroblast differentiation and function. J. Investig. Dermatol. 2010, 130:2818-2827.
233. Moller-Pedersen T., Cavanagh H.D., Petroll W.M., Jester J.V. Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. Curr. Eye Res. 1998, 17:736-747.
234. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
235. Moulin V., Castilloux G., Auger F.A., Garrel D., O'Connor-McCourt M.D., Germain L. Modulated response to cytokines of human wound healing myofibroblasts compared to dermal fibroblasts. Exp. Cell Res. 1998, 238:283-293.
236. Myrna K.E., Mendonsa R., Russell P., Pot S.A., Liliensiek S.J., Jester J.V., Nealey P.F., Brown D., Murphy C.J. Substratum topography modulates corneal fibroblast to myofibroblast transformation. Investig. Ophthalmol. Vis. Sci. 2012, 53:811-816.
237. Myrna K.E., Pot S.A., Murphy C.J. Meet the corneal myofibroblast: the role of myofibroblast transformation in corneal wound healing and pathology. Vet. Ophthalmol. 2009, 12(Suppl. 1):25-27.
238. Nakamura K. Interaction between injured corneal epithelial cells and stromal cells. Cornea 2003, 22:S35-S47.
239. Nakamura K., Kurosaka D., Yoshino M., Oshima T., Kurosaka H. Injured corneal epithelial cells promote myodifferentiation of corneal fibroblasts. Investig. Ophthalmol. Vis. Sci. 2002, 43:2603-2608.
240. Nakano Y., Oyamada M., Dai P., Nakagami T., Kinoshita S., Takamatsu T. Connexin43 knockdown accelerates wound healing but inhibits mesenchymal transition after corneal endothelial injury in vivo. Investig. Ophthalmol. Vis. Sci. 2008, 49:93-104.
241. Nilsen-Hamilton M. Transforming growth factor-beta and its actions on cellular growth and differentiation. Curr. Top. Dev. Biol. 1990, 24:95-136.
242. Nishi O., Nishi K., Fujiwara T., Shirasawa E., Ohmoto Y. Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells. Br. J. Ophthalmol. 1996, 80:63-68.
243. Noble P.W., Barkauskas C.E., Jiang D. Pulmonary fibrosis: patterns and perpetrators. J. Clin. Investig. 2012, 122:2756-2762.
244. Novotny G.E., Pau H. Myofibroblast-like cells in human anterior capsular cataract. Virchows Arch. A Pathol. Anat. Histopathol. 1984, 404:393-401.
245. O'Connor J.W., Riley P.N., Nalluri S.M., Ashar P.K., Gomez E.W. Matrix rigidity mediates TGFbeta1-induced epithelial-myofibroblast transition by controlling cytoskeletal organization and MRTF-A localization. J. Cell Physiol. 2014, 230:1829-1839.
246. Okada Y., Reinach P.S., Shirai K., Kitano A., Kao W.W., Flanders K.C., Miyajima M., Liu H., Zhang J., Saika S. TRPV1 involvement in inflammatory tissue fibrosis in mice. Am. J. Pathol. 2011, 178:2654-2664.
247. Okumura N., Kay E.P., Nakahara M., Hamuro J., Kinoshita S., Koizumi N. Inhibition of TGF-beta signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine. PLoS One 2013, 8:e58000.
248. Oldroyd S.D., Thomas G.L., Gabbiani G., El Nahas A.M. Interferon-gamma inhibits experimental renal fibrosis. Kidney Int. 1999, 56:2116-2127.
249. Olsen A.L., Bloomer S.A., Chan E.P., Gaca M.D., Georges P.C., Sackey B., Uemura M., Janmey P.A., Wells R.G. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G110-G118.
250. Olson L.E., Soriano P. Increased PDGFRalpha activation disrupts connective tissue development and drives systemic fibrosis. Dev. Cell 2009, 16:303-313.
251. Osterreicher C.H., Penz-Osterreicher M., Grivennikov S.I., Guma M., Koltsova E.K., Datz C., Sasik R., Hardiman G., Karin M., Brenner D.A. Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver. Proc. Natl. Acad. Sci. U. S. A. 2010, 108:308-313.
252. Pakkar A., Rofougaran R., Lu K., Wee W.R., Isfahani A.K., McDonnell P.J. Effects of gamma-interferon on keratocyte-induced collagen gel contraction and keratocyte proliferation. J. Refract Surg. 1998, 14:152-155.
253. Papetti M., Shujath J., Riley K.N., Herman I.M. FGF-2 antagonizes the TGF-beta1-mediated induction of pericyte alpha-smooth muscle actin expression: a role for myf-5 and Smad-mediated signaling pathways. Investig. Ophthalmol. Vis. Sci. 2003, 44:4994-5005.
254. Parapuram S.K., Chang B., Li L., Hartung R.A., Chalam K.V., Nair-Menon J.U., Hunt D.M., Hunt R.C. Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells. Investig. Ophthalmol. Vis. Sci. 2009, 50:5965-5974.
255. Park H.Y., Kim J.H., Park C.K. VEGF induces TGF-beta1 expression and myofibroblast transformation after glaucoma surgery. Am. J. Pathol. 2013, 182:2147-2154.
256. Park J.S., Chu J.S., Tsou A.D., Diop R., Tang Z., Wang A., Li S. The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-beta. Biomaterials 2011, 32:3921-3930.
257. Park K., Lee K., Zhang B., Zhou T., He X., Gao G., Murray A.R., Ma J.X. Identification of a novel inhibitor of the canonical Wnt pathway. Mol. Cell Biol. 2011, 31:3038-3051.
258. Pattabiraman P.P., Maddala R., Rao P.V. Regulation of plasticity and fibrogenic activity of trabecular meshwork cells by Rho GTPase signaling. J. Cell Physiol. 2014, 229:927-942.
259. Pei Y., Sherry D.M., McDermott A.M. Thy-1 distinguishes human corneal fibroblasts and myofibroblasts from keratocytes. Exp. Eye Res. 2004, 79:705-712.
260. Penke L.R., Huang S.K., White E.S., Peters-Golden M. Prostaglandin E2 inhibits alpha-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A. J. Biol. Chem. 2014, 289:17151-17162.
261. Perepelyuk M., Terajima M., Wang A.Y., Georges P.C., Janmey P.A., Yamauchi M., Wells R.G. Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304:G605-G614.
262. Peters T., Sindrilaru A., Hinz B., Hinrichs R., Menke A., Al-Azzeh E.A., Holzwarth K., Oreshkova T., Wang H., Kess D., Walzog B., Sulyok S., Sunderkotter C., Friedrich W., Wlaschek M., Krieg T., Scharffetter-Kochanek K. Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J. 2005, 24:3400-3410.
263. Petroll W.M., Jester J.V., Bean J.J., Cavanagh H.D. Myofibroblast transformation of cat corneal endothelium by transforming growth factor-beta1, -beta2, and -beta3. Investig. Ophthalmol. Vis. Sci. 1998, 39:2018-2032.
264. Petroll W.M., Lakshman N. Fibroblastic transformation of corneal keratocytes by Rac inhibition is modulated by extracellular matrix structure and stiffness. J. Funct. Biomater. 2015, 6:222-240.
265. Petroll W.M., Miron-Mendoza M. Mechanical interactions and crosstalk between corneal keratocytes and the extracellular matrix. Exp. Eye Res. 2015, 133:49-57.
266. Phanish M.K., Winn S.K., Dockrell M.E. Connective tissue growth factor-(CTGF, CCN2)-a marker, mediator and therapeutic target for renal fibrosis. Nephron. Exp. Nephrol. 2010, 114:e83-92.
267. Pickup M.W., Mouw J.K., Weaver V.M. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 2014, 15:1243-1253.
268. Pot S.A., Liliensiek S.J., Myrna K.E., Bentley E., Jester J.V., Nealey P.F., Murphy C.J. Nanoscale topography-induced modulation of fundamental cell behaviors of rabbit corneal keratocytes, fibroblasts, and myofibroblasts. Investig. Ophthalmol. Vis. Sci. 2010, 51:1373-1381.
269. Proetzel G., Pawlowski S.A., Wiles M.V., Yin M., Boivin G.P., Howles P.N., Ding J., Ferguson M.W., Doetschman T. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat. Genet. 1995, 11:409-414.
270. Quaggin S.E., Kapus A. Scar wars: mapping the fate of epithelial-mesenchymal-myofibroblast transition. Kidney Int. 2011, 80:41-50.
271. Quinlan A.M., Billiar K.L. Investigating the role of substrate stiffness in the persistence of valvular interstitial cell activation. J. Biomed. Mater Res. A 2012, 100:2474-2482.
272. Radhakrishnan S.S., Blalock T.D., Robinson P.M., Secker G., Daniels J., Grotendorst G.R., Schultz G.S. Effect of connective tissue growth factor on protein kinase expression and activity in human corneal fibroblasts. Investig. Ophthalmol. Vis. Sci. 2012, 53:8076-8085.
273. Radisky D.C., Kenny P.A., Bissell M.J. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?. J. Cell Biochem. 2007, 101:830-839.
274. Raghunathan V.K., Morgan J.T., Dreier B., Reilly C.M., Thomasy S.M., Wood J.A., Ly I., Tuyen B.C., Hughbanks M., Murphy C.J., Russell P. Role of substratum stiffness in modulating genes associated with extracellular matrix and mechanotransducers YAP and TAZ. Investig. Ophthalmol. Vis. Sci. 2013, 54:378-386.
275. Rahaman S.O., Grove L.M., Paruchuri S., Southern B.D., Abraham S., Niese K.A., Scheraga R.G., Ghosh S., Thodeti C.K., Zhang D.X., Moran M.M., Schilling W.P., Tschumperlin D.J., Olman M.A. TRPV4 mediates myofibroblast differentiation and pulmonary fibrosis in mice. J. Clin. Investig. 2014, 124:5225-5238.
276. Ramirez F., Rifkin D.B. Extracellular microfibrils: contextual platforms for TGFbeta and BMP signaling. Curr. Opin. Cell Biol. 2009, 21:616-622.
277. Rinkevich Y., Walmsley G.G., Hu M.S., Maan Z.N., Newman A.M., Drukker M., Januszyk M., Krampitz G.W., Gurtner G.C., Lorenz H.P., Weissman I.L., Longaker M.T. Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science 2015, 348:aaa2151.
278. Robertson I.B., Rifkin D.B. Unchaining the beast; insights from structural and evolutionary studies on TGFbeta secretion, sequestration, and activation. Cytokine Growth Factor Rev. 2013, 24:355-372.
279. Rockey D.C., Maher J.J., Jarnagin W.R., Gabbiani G., Friedman S.L. Inhibition of rat hepatic lipocyte activation in culture by interferon- gamma. Hepatology 1992, 16:776-784.
280. Rønnov-Jessen L., Petersen O.W. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab. Investig. 1993, 68:696-707.
281. Rønnov-Jessen L., Petersen O.W. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts. J. Cell Biol. 1996, 134:67-80.
282. Ruberti J.W., Roy A.S., Roberts C.J. Corneal biomechanics and biomaterials. Annu. Rev. Biomed. Eng. 2011, 13:269-295.
283. Ryan D.G., Taliana L., Sun L., Wei Z.G., Masur S.K., Lavker R.M. Involvement of S100A4 in stromal fibroblasts of the regenerating cornea. Investig. Ophthalmol. Vis. Sci. 2003, 44:4255-4262.
284. Saika S., Miyamoto T., Tanaka S., Tanaka T., Ishida I., Ohnishi Y., Ooshima A., Ishiwata T., Asano G., Chikama T., Shiraishi A., Liu C.Y., Kao C.W., Kao W.W. Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Investig. Ophthalmol. Vis. Sci. 2003, 44:2094-2102.
285. Saika S., Miyamoto T., Tanaka T., Ishida I., Ohnishi Y., Ooshima A. Latent TGFbeta binding protein-1 and fibrillin-1 in human capsular opacification and in cultured lens epithelial cells. Br. J. Ophthalmol. 2001, 85:1362-1366.
286. Saika S., Yamanaka O., Okada Y., Tanaka S., Miyamoto T., Sumioka T., Kitano A., Shirai K., Ikeda K. TGF beta in fibroproliferative diseases in the eye. Front. Biosci. Sch. Ed. 2009, 1:376-390.
287. Sanford L.P., Ormsby I., Gittenberger-de Groot A.C., Sariola H., Friedman R., Boivin G.P., Cardell E.L., Doetschman T. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997, 124:2659-2670.
288. Santhiago M.R., Singh V., Barbosa F.L., Agrawal V., Wilson S.E. Monocyte development inhibitor PRM-151 decreases corneal myofibroblast generation in rabbits. Exp. Eye Res. 2011, 93:786-789.
289. Sarrazy V., Koehler A., Chow M.L., Zimina E., Li C.X., Kato H., Caldarone C.A., Hinz B. Integrins alphavbeta5 and alphavbeta3 promote latent TGF-beta1 activation by human cardiac fibroblast contraction. Cardiovasc Res. 2014, 102:407-417.
290. Saums M.K., Wang W., Han B., Madhavan L., Han L., Lee D., Wells R.G. Mechanically and chemically tunable cell culture system for studying the myofibroblast phenotype. Langmuir 2014, 30:5481-5487.
291. Scharenberg M.A., Pippenger B.E., Sack R., Zingg D., Ferralli J., Schenk S., Martin I., Chiquet-Ehrismann R. TGF-beta-induced differentiation into myofibroblasts involves specific regulation of two MKL1 isoforms. J. Cell Sci. 2014, 127:1079-1091.
292. Schlotzer-Schrehardt U., Zenkel M., Kuchle M., Sakai L.Y., Naumann G.O. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp. Eye Res. 2001, 73:765-780.
293. Schmitt-Graff A., Pau H., Spahr R., Piper H.M., Skalli O., Gabbiani G. Appearance of alpha-smooth muscle actin in human eye lens cells of anterior capsular cataract and in cultured bovine lens-forming cells. Differentiation 1990, 43:115-122.
294. Schwartzfarb E., Kirsner R.S. Understanding scarring: scarless fetal wound healing as a model. J. Investig. Dermatol. 2012, 132:260.
295. Serini G., Gabbiani G. Modulation of alpha-smooth muscle actin expression in fibroblasts by transforming growth factor-beta isoforms: an in vivo and in vitro study. Wound Rep. Reg. 1996, 4:278-287.
296. Shah M., Foreman D.M., Ferguson M.W. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 1992, 339:213-214.
297. Shah M., Foreman D.M., Ferguson M.W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 1995, 108(Pt 3):985-1002.
298. Shen H., Yao P., Lee E., Greenhalgh D., Soulika A.M. Interferon-gamma inhibits healing post scald burn injury. Wound Repair Regen. 2012, 20:580-591.
299. Shephard P., Martin G., Smola-Hess S., Brunner G., Krieg T., Smola H. Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. Am. J. Pathol. 2004, 164:2055-2066.
300. Shi-Wen X., Leask A., Abraham D. Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev. 2008, 19:133-144.
301. Shi M., Zhu J., Wang R., Chen X., Mi L., Walz T., Springer T.A. Latent TGF-beta structure and activation. Nature 2011, 474:343-349.
302. Shiwen X., Stratton R., Nikitorowicz-Buniak J., Ahmed-Abdi B., Ponticos M., Denton C., Abraham D., Takahashi A., Suki B., Layne M.D., Lafyatis R., Smith B.D. A role of myocardin related transcription factor-a (MRTF-A) in scleroderma related fibrosis. PLoS One 2015, 10:e0126015.
303. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., Doetschman T. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
304. Simpson R.M., Meran S., Thomas D., Stephens P., Bowen T., Steadman R., Phillips A. Age-related changes in pericellular hyaluronan organization leads to impaired dermal fibroblast to myofibroblast differentiation. Am. J. Pathol. 2009, 175:1915-1928.
305. Singer I.I., Kazazis D.M., Kawka D.W. Localization of the fibronexus at the surface of granulation tissue myofibroblasts using double-label immunogold electron microscopy on ultrathin frozen sections. Eur. J. Cell Biol. 1985, 38:94-101.
306. Singh V., Jaini R., Torricelli A.A., Santhiago M.R., Singh N., Ambati B.K., Wilson S.E. TGFbeta and PDGF-B signaling blockade inhibits myofibroblast development from both bone marrow-derived and keratocyte-derived precursor cells in vivo. Exp. Eye Res. 2014, 121:35-40.
307. Singh V., Jaini R., Torricelli A.A., Tuohy V.K., Wilson S.E. A method to generate enhanced GFP+ chimeric mice to study the role of bone marrow-derived cells in the eye. Exp. Eye Res. 2013, 116:366-370.
308. Singh V., Santhiago M.R., Barbosa F.L., Agrawal V., Singh N., Ambati B.K., Wilson S.E. Effect of TGFbeta and PDGF-B blockade on corneal myofibroblast development in mice. Exp. Eye Res. 2011, 93:810-817.
309. Sisson T.H., Ajayi I.O., Subbotina N., Dodi A.E., Rodansky E.S., Chibucos L.N., Kim K.K., Keshamouni V.G., White E.S., Zhou Y., Higgins P.D., Larsen S.D., Neubig R.R., Horowitz J.C. Inhibition of myocardin-related transcription factor/serum response factor signaling decreases lung fibrosis and promotes mesenchymal cell apoptosis. Am. J. Pathol. 2015, 185:969-986.
310. Sivakumar P., Ntolios P., Jenkins G., Laurent G. Into the matrix: targeting fibroblasts in pulmonary fibrosis. Curr. Opin. Pulm. Med. 2012, 18:462-469.
311. Skalli O., Ropraz P., Trzeciak A., Benzonana G., Gillessen D., Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol. 1986, 103:2787-2796.
312. Small E.M., Thatcher J.E., Sutherland L.B., Kinoshita H., Gerard R.D., Richardson J.A., Dimaio J.M., Sadek H., Kuwahara K., Olson E.N. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ. Res. 2010, 107:294-304.
313. Sobral L.M., Montan P.F., Martelli-Junior H., Graner E., Coletta R.D. Opposite effects of TGF-beta1 and IFN-gamma on transdifferentiation of myofibroblast in human gingival cell cultures. J. Clin. Periodontol. 2007, 34:397-406.
314. Song K., Nam Y.J., Luo X., Qi X., Tan W., Huang G.N., Acharya A., Smith C.L., Tallquist M.D., Neilson E.G., Hill J.A., Bassel-Duby R., Olson E.N. Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012, 485:599-604.
315. Song Y., Zhan L., Yu M., Huang C., Meng X., Ma T., Zhang L., Li J. TRPV4 channel inhibits TGF-beta1-induced proliferation of hepatic stellate cells. PLoS One 2014, 9:e101179.
316. Sorrell J.M., Caplan A.I. Fibroblasts-a diverse population at the center of it all. Int. Rev. Cell Mol. Biol. 2009, 276:161-214.
317. Speight P., Nakano H., Kelley T.J., Hinz B., Kapus A. Differential topical susceptibility to TGFbeta in intact and injured regions of the epithelium: key role in myofibroblast transition. Mol. Biol. Cell 2013, 24:3326-3336.
318. Spurlin J.W., Lwigale P.Y. Wounded embryonic corneas exhibit nonfibrotic regeneration and complete innervation. Investig. Ophthalmol. Vis. Sci. 2013, 54:6334-6344.
319. Stepp M.A. Corneal integrins and their functions. Exp. Eye Res. 2006, 83:3-15.
320. Stepp M.A., Zieske J.D., Trinkaus-Randall V., Kyne B.M., Pal-Ghosh S., Tadvalkar G., Pajoohesh-Ganji A. Wounding the cornea to learn how it heals. Exp. Eye Res. 2014, 121:178-193.
321. Storm C., Pastore J.J., MacKintosh F.C., Lubensky T.C., Janmey P.A. Nonlinear elasticity in biological gels. Nature 2005, 435:191-194.
322. Sweetwyne M.T., Murphy-Ullrich J.E. Thrombospondin1 in tissue repair and fibrosis: TGF-beta-dependent and independent mechanisms. Matrix Biol. 2012, 31:178-186.
323. Takeda N., Manabe I., Uchino Y., Eguchi K., Matsumoto S., Nishimura S., Shindo T., Sano M., Otsu K., Snider P., Conway S.J., Nagai R. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Invest 2010, 120:254-265.
324. Talele N., Fradette J., Davies J.E., Kapus A., Hinz B. Expression of α-smooth muscle actin determines the fate of mesenchymal stromal cells. Stem Cell Rep. 2015, 4:1016-1030.
325. Tan J., Tong B.D., Wu Y.J., Xiong W. MicroRNA-29 mediates TGFbeta1-induced extracellular matrix synthesis by targeting Wnt/beta-catenin pathway in human orbital fibroblasts. Int. J. Clin. Exp. Pathol. 2014, 7:7571-7577.
326. Tanaka K., Sano K., Yuba K., Katsumura K., Nakano T., Kobayashi M., Ikeda T., Abe M. Inhibition of induction of myofibroblasts by interferon gamma in a human fibroblast cell line. Int. Immunopharmacol. 2003, 3:1273-1280.
327. Tandon A., Tovey J.C., Sharma A., Gupta R., Mohan R.R. Role of transforming growth factor beta in corneal function, biology and pathology. Curr. Mol. Med. 2010, 10:565-578.
328. Tatler A.L., Jenkins G. TGF-beta activation and lung fibrosis. Proc. Am. Thorac. Soc. 2012, 9:130-136.
329. Tatler A.L., John A.E., Jolly L., Habgood A., Porte J., Brightling C., Knox A.J., Pang L., Sheppard D., Huang X., Jenkins G. Integrin alphavbeta5-mediated TGF-beta activation by airway smooth muscle cells in asthma. J. Immunol. 2011, 187:6094-6107.
330. Thom S.B., Myers J.S., Rapuano C.J., Eagle R.C., Siepser S.B., Gomes J.A. Effect of topical anti-transforming growth factor-beta on corneal stromal haze after photorefractive keratectomy in rabbits. J. Cataract. Refract Surg. 1997, 23:1324-1330.
331. Thomasy S.M., Raghunathan V.K., Winkler M., Reilly C.M., Sadeli A.R., Russell P., Jester J.V., Murphy C.J. Elastic modulus and collagen organization of the rabbit cornea: epithelium to endothelium. Acta Biomater. 2014, 10:785-791.
332. Thomasy S.M., Wood J.A., Kass P.H., Murphy C.J., Russell P. Substratum stiffness and latrunculin B regulate matrix gene and protein expression in human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 2012, 53:952-958.
333. Tomasek J.J., Gabbiani G., Hinz B., Chaponnier C., Brown R.A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 2002, 3:349-363.
334. Torricelli A.A., Wilson S.E. Cellular and extracellular matrix modulation of corneal stromal opacity. Exp. Eye Res. 2014, 129:151-160.
335. Travis M.A., Sheppard D. TGF-beta activation and function in immunity. Annu. Rev. Immunol. 2014, 32:51-82.
336. Trese M.T., Chandler D.B., Machemer R. Subretinal strands: ultrastructural features. Graefes Arch. Clin. Exp. Ophthalmol. 1985, 223:35-40.
337. Troeger J.S., Mederacke I., Gwak G.Y., Dapito D.H., Mu X., Hsu C.C., Pradere J.P., Friedman R.A., Schwabe R.F. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 2012, 143:1073-1083.
338. Tuli S.S., Liu R., Chen C., Blalock T.D., Goldstein M., Schultz G.S. Immunohistochemical localization of EGF, TGF-alpha, TGF-beta, and their receptors in rat corneas during healing of excimer laser ablation. Curr. Eye Res. 2006, 31:709-719.
339. Turner N.A., Porter K.E. Function and fate of myofibroblasts after myocardial infarction. Fibrogenes. Tissue Repair 2013, 6:5.
340. Twarock S., Tammi M.I., Savani R.C., Fischer J.W. Hyaluronan stabilizes focal adhesions, filopodia, and the proliferative phenotype in esophageal squamous carcinoma cells. J. Biol. Chem. 2010, 285:23274-23282.
341. Van Bergen T., Marshall D., Van de Veire S., Vandewalle E., Moons L., Herman J., Smith V., Stalmans I. The role of LOX and LOXL2 in scar formation after glaucoma surgery. Investig. Ophthalmol. Vis. Sci. 2013, 54:5788-5796.
342. Varga J., Pasche B. Antitransforming growth factor-beta therapy in fibrosis: recent progress and implications for systemic sclerosis. Curr. Opin. Rheumatol. 2008, 20:720-728.
343. Verhoekx J.S., Verjee L.S., Izadi D., Chan J.K., Nicolaidou V., Davidson D., Midwood K.S., Nanchahal J. Isometric contraction of Dupuytren's myofibroblasts is inhibited by blocking intercellular junctions. J. Investig. Dermatol. 2013, 133:2664-2671.
344. Vi L., Feng L., Zhu R.D., Wu Y., Satish L., Gan B.S., O'Gorman D.B. Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells. Exp. Cell Res. 2009, 315:3574-3586.
345. Wallace D.M., Murphy-Ullrich J.E., Downs J.C., O'Brien C.J. The role of matricellular proteins in glaucoma. Matrix Biol. 2014, 37:174-182.
346. Walshe R., Esser P., Wiedemann P., Heimann K. Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction. Br. J. Ophthalmol. 1992, 76:550-552.
347. Wang D., Park J.S., Chu J.S., Krakowski A., Luo K., Chen D.J., Li S. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor beta1 stimulation. J. Biol. Chem. 2004, 279:43725-43734.
348. Wang H., Haeger S.M., Kloxin A.M., Leinwand L.A., Anseth K.S. Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One 2012, 7:e39969.
349. Wang Q., Usinger W., Nichols B., Gray J., Xu L., Seeley T.W., Brenner M., Guo G., Zhang W., Oliver N., Lin A., Yeowell D. Cooperative interaction of CTGF and TGF-beta in animal models of fibrotic disease. Fibrogenes. Tissue Repair 2011, 4:4.
350. Webber J., Jenkins R.H., Meran S., Phillips A., Steadman R. Modulation of TGFbeta1-dependent myofibroblast differentiation by hyaluronan. Am. J. Pathol. 2009, 175:148-160.
351. Weber K.T., Sun Y., Bhattacharya S.K., Ahokas R.A., Gerling I.C. Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 2013, 10:15-26.
352. Wei J., Melichian D., Komura K., Hinchcliff M., Lam A.P., Lafyatis R., Gottardi C.J., MacDougald O.A., Varga J. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?. Arthritis Rheum. 2011, 63:1707-1717.
353. Weinl C., Riehle H., Park D., Stritt C., Beck S., Huber G., Wolburg H., Olson E.N., Seeliger M.W., Adams R.H., Nordheim A. Endothelial SRF/MRTF ablation causes vascular disease phenotypes in murine retinae. J. Clin. Investig. 2013, 123:2193-2206.
354. Werner S., Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 2003, 83:835-870.
355. West-Mays J.A., Dwivedi D.J. The keratocyte: corneal stromal cell with variable repair phenotypes. Int. J. Biochem. Cell Biol. 2006, 38:1625-1631.
356. Wilson S.E. Corneal myofibroblast biology and pathobiology: generation, persistence, and transparency. Exp. Eye Res. 2012, 99:78-88.
357. Wilson S.E., Chaurasia S.S., Medeiros F.W. Apoptosis in the initiation, modulation and termination of the corneal wound healing response. Exp. Eye Res. 2007, 85:305-311.
358. Wilson S.E., Mohan R.R., Mohan R.R., Ambrosio R., Hong J., Lee J. The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells. Prog. Retin Eye Res. 2001, 20:625-637.
359. Wilson S.E., Mohan R.R., Netto M., Perez V., Possin D., Huang J., Kwon R., Alekseev A., Rodriguez-Perez J.P. RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. Investig. Ophthalmol. Vis. Sci. 2004, 45:2201-2211.
360. Winer J.P., Janmey P.A., McCormick M.E., Funaki M. Bone marrow-derived human mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli. Tissue Eng. Part A 2009, 15:147-154.
361. Wipff P.J., Hinz B. Integrins and the activation of latent transforming growth factor beta1-an intimate relationship. Eur. J. Cell Biol. 2008, 87:601-615.
362. Wipff P.J., Rifkin D.B., Meister J.J., Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 2007, 179:1311-1323.
363. Wollin L., Maillet I., Quesniaux V., Holweg A., Ryffel B. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis. J. Pharmacol. Exp. Ther. 2014, 349:209-220.
364. Worthington J.J., Klementowicz J.E., Travis M.A. TGFbeta: a sleeping giant awoken by integrins. Trends Biochem. Sci. 2011, 36:47-54.
365. Wynn T.A., Chawla A., Pollard J.W. Macrophage biology in development, homeostasis and disease. Nature 2013, 496:445-455.
366. Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 2012, 18:1028-1040.
367. Xi X., McMillan D.H., Lehmann G.M., Sime P.J., Libby R.T., Huxlin K.R., Feldon S.E., Phipps R.P. Ocular fibroblast diversity: implications for inflammation and ocular wound healing. Investig. Ophthalmol. Vis. Sci. 2011, 52:4859-4865.
368. Xing D., Bonanno J.A. Hypoxia reduces TGFbeta1-induced corneal keratocyte myofibroblast transformation. Mol. Vis. 2009, 15:1827-1834.
369. Yamaguchi M., Shima N., Kimoto M., Ebihara N., Murakami A., Yamagami S. Markers for distinguishing cultured human corneal endothelial cells from corneal stromal myofibroblasts. Curr. Eye Res. 2014, 1-7.
370. Yamamoto M., Quantock A.J., Young R.D., Okumura N., Ueno M., Sakamoto Y., Kinoshita S., Koizumi N. A selective inhibitor of the rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma. Mol. Vis. 2012, 18:1727-1739.
371. Yang Y., Wang Z., Yang H., Wang L., Gillespie S.R., Wolosin J.M., Bernstein A.M., Reinach P.S. TRPV1 potentiates TGFbeta-induction of corneal myofibroblast development through an oxidative stress-mediated p38-SMAD2 signaling loop. PLoS One 2013, 8:e77300.
372. Yang Y., Yang H., Wang Z., Mergler S., Wolosin J.M., Reinach P.S. Functional TRPV1 expression in human corneal fibroblasts. Exp. Eye Res. 2013, 107:121-129.
373. Yokozeki M., Baba Y., Shimokawa H., Moriyama K., Kuroda T. Interferon-gamma inhibits the myofibroblastic phenotype of rat palatal fibroblasts induced by transforming growth factor-beta1 in vitro. FEBS Lett. 1999, 442:61-64.
374. Yu-Wai-Man C., Treisman R., Bailly M., Khaw P.T. The role of the MRTF-A/SRF pathway in ocular fibrosis. Investig. Ophthalmol. Vis. Sci. 2014, 55:4560-4567.
375. Yu H., Mouw J.K., Weaver V.M. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol. 2011, 21:47-56.
376. Zeisberg M., Duffield J.S. Resolved: EMT produces fibroblasts in the kidney. J. Am. Soc. Nephrol. 2010, 21:1247-1253.
377. Zhao W., Zhao T., Huang V., Chen Y., Ahokas R.A., Sun Y. Platelet-derived growth factor involvement in myocardial remodeling following infarction. J. Mol. Cell Cardiol. 2011, 51:830-838.
378. Zhou Y., Huang X., Hecker L., Kurundkar D., Kurundkar A., Liu H., Jin T.H., Desai L., Bernard K., Thannickal V.J. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J. Clin. Invest 2013, 123:1096-1108.
379. Zilberberg L., Todorovic V., Dabovic B., Horiguchi M., Courousse T., Sakai L.Y., Rifkin D.B. Specificity of latent TGF-beta binding protein (LTBP) incorporation into matrix: role of fibrillins and fibronectin. J. Cell Physiol. 2012, 227:3828-3836.